Cargando…
Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
Parkinson’s disease (PD) is a neurodegenerative disorder that carries large health and socioeconomic burdens. Current therapies for PD are ultimately inadequate, both in terms of symptom control and in modification of disease progression. Deep brain stimulation and infusion therapies are the current...
Autores principales: | Buttery, Philip C., Barker, Roger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598241/ https://www.ncbi.nlm.nih.gov/pubmed/33128174 http://dx.doi.org/10.1007/s13311-020-00940-4 |
Ejemplares similares
-
Treating Parkinson’s disease in the 21st century: Can stem cell transplantation compete?
por: Buttery, Philip C, et al.
Publicado: (2014) -
Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?
por: Mourtzi, Theodora, et al.
Publicado: (2022) -
Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020) -
Subtyping of Parkinson’s Disease - Where Are We Up To?
por: Qian, Elizabeth, et al.
Publicado: (2019) -
Cell therapies for Parkinson's disease: how far have we come?
por: Stoker, Thomas B, et al.
Publicado: (2016)